MSI-L/EMAST is a predictive biomarker for metastasis in colorectal cancer patients.

Amir T EsfahaniSeyed Yoosef SeyednaEhsan Nazemalhosseini MojaradAhmad MajdHamid Asadzadeh Aghdaei

Published in: Journal of cellular physiology (2018)

MSI-L tumors have different clinicopathological features from MSS and MSI-H tumors. The MSI-L phenotype is a worse prognostic biomarker in CRC and when accompanied by EMAST could be a predictor for metastasis.

Keyphrases